Magic mushrooms can ease depression resistant to other treatments, major study finds
A major study finds that psilocybin, the active compound in magic mushrooms, can help treat depression that resists other therapies.
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 4.
Source diversity sample: Magzter · The Clinical Trial Vanguard · Medical Xpress · The Telegraph · Nature · The Independent.
How this dossier is built: methodology · AI policy · corrections.
Questions people are asking
What is psilocybin?
Psilocybin is the active compound found in magic mushrooms. It has shown promise in treating depression, particularly in cases resistant to other treatments.
What did the study published in Nature find?
The study found that a single dose of psilocybin-assisted therapy showed promising results in treating treatment-resistant major depressive disorder in a public healthcare setting.
Why have clinical guidelines not been updated?
The Clinical Trial Vanguard notes that while psilocybin has crossed the evidence threshold, clinical guidelines have not yet been updated to reflect these findings.
What happened
The UK's first publicly funded randomized trial, published in Nature, found that a single dose of psilocybin-assisted therapy showed promising results. The Clinical Trial Vanguard notes that while psilocybin has crossed the evidence threshold, clinical guidelines have not yet caught up. The Telegraph, Medical Xpress and The Independent also covered the story.
The evidence comes from a randomized controlled trial published in Nature. The study, conducted in a public healthcare setting, focused on treatment-resistant major depressive disorder. Participants received psilocybin-assisted therapy, and the results indicated significant improvements in depressive symptoms.
The caveat is that clinical guidelines have not yet been updated to reflect these findings. According to The Clinical Trial Vanguard, while the evidence for psilocybin's efficacy is strong, the integration of this treatment into standard clinical practice is still pending.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (89% supported) Updated 1h ago.
Sources (6)
- Magic mushroom psychedelic ‘can help depression’ | Scottish Daily Express Magzter · 1d ago
- Psilocybin Has Crossed the Evidence Threshold. Clinical Guidelines Have Not. The Clinical Trial Vanguard · 1d ago
- Single dose of psilocybin for depression shows promising results in UK's first publicly funded randomized trial Medical Xpress · 1d ago
- Psychedelic in magic mushrooms can ease depression The Telegraph · 1d ago
- Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial Nature · 1d ago
- Magic mushrooms can ease depression resistant to other treatments, major study finds The Independent · 1d ago
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Kalshi Defends Plan to Bet on Lives of Cancer Patients
Kalshi is defending its plan to allow betting on the lives of cancer patients, sparking widespread debate.
Dronabinol for nightmares in post-traumatic stress disorder: a randomized controlled trial
A randomized controlled trial finds THC effective in reducing trauma-related nightmares in PTSD patients.
Encapsulation epitaxy of air-stable 2D superconductors for quantum circuits
Scientists have created air-stable 2D superconductors, a breakthrough that could revolutionize quantum computing.
Meta told to pay another $567m in New Mexico child safety lawsuit
Meta faces a $567 million penalty in New Mexico for harm to children's mental health on its platforms.
Joe Jonas reveals underperforming solo album sales led him to therapy
Joe Jonas' candid admission about his mental health struggle after his solo album's underperformance has sparked widespread discussion.
Perez Hilton's TikTok Livestream Was Kept Up Due To "Moderator Error," Spokesperson Says
Perez Hilton's TikTok livestream showing self-harm was left up due to a moderator error, according to TikTok.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.